Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
Clinical trial NCT06858722 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06858722
- Sponsor
- Zhongming Qiu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-15
- Primary completion
- 2027-06-30
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.